Biocept Reports Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Biocept (BIOC) Misses Q3 EPS by $0.03
November 15, 2021 4:14 PM ESTBiocept (NASDAQ: BIOC) reported Q3 EPS of $0.03, $0.03 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $17.5 million versus the consensus estimate of $16.07 million.
For earnings history and earnings-related data on Biocept (BIOC) click here.
... More


